Bcal Diagnostics Ltd (BDX) — Capital Reinvestment Ratio
Latest as of December 2020:
0.02x
Bcal Diagnostics Ltd (BDX) has a Capital Reinvestment Ratio of 0.02x as of December 2020, meaning it reinvests 0% of its operating cash flow (AU$118.98K) in capital expenditures (AU$1.93K). See Bcal Diagnostics Ltd balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
AU$118.98K
AUD
Capital Expenditures
AU$1.93K
AUD
Data as of
Dec 2020
Most recent filing
Annual Capital Reinvestment Ratio for Bcal Diagnostics Ltd (None–None)
Year-by-year Capital Reinvestment Ratio for Bcal Diagnostics Ltd from None to None. For live market cap and broader valuation context, see BDX market cap overview.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow